Vulva Neoplasms and common benign lesions Maria Horvat, MD, FACOG.

31
Vulva Neoplasms and common benign lesions Maria Horvat, MD, FACOG

Transcript of Vulva Neoplasms and common benign lesions Maria Horvat, MD, FACOG.

Page 1: Vulva Neoplasms and common benign lesions Maria Horvat, MD, FACOG.

VulvaNeoplasms and common benign lesions

Maria Horvat, MD, FACOG

Page 2: Vulva Neoplasms and common benign lesions Maria Horvat, MD, FACOG.

Anatomy of the vulva

Page 3: Vulva Neoplasms and common benign lesions Maria Horvat, MD, FACOG.

Lymphatic drainage of the vulva

Page 4: Vulva Neoplasms and common benign lesions Maria Horvat, MD, FACOG.

Vulvar Cancer

5% of female genital malignanciesUsually occurs in the 70-80 year old populationHistology is necessary for diagnosisOccurs anywhere on vulvaSurgically stagedMost common type is squamous cellMelanoma is 2nd most common – but still <5% Associated with HPV

Page 5: Vulva Neoplasms and common benign lesions Maria Horvat, MD, FACOG.

Vulvar Cancer

Spreads by direct extension

Embolizes to lymphatics

Hematogenous dissemination

Page 6: Vulva Neoplasms and common benign lesions Maria Horvat, MD, FACOG.

Risks of vulvar cancer

HPV

Lichen sclerosis

Long history of puritis

Lymph nodes are single most important prognostic factor

Page 7: Vulva Neoplasms and common benign lesions Maria Horvat, MD, FACOG.

Vulvar Intraepithelial Neoplasms

VIN - preinvasive disease

VIN 1

VIN 2

VIN3

Page 8: Vulva Neoplasms and common benign lesions Maria Horvat, MD, FACOG.

Vulvar Intraepithelial Neoplasms

VIN 1Abnormal cellular changes

Confined to lower 1/3

Epithelium – no progressive vulvar cancer

Page 9: Vulva Neoplasms and common benign lesions Maria Horvat, MD, FACOG.

Vulvar Intraepithelial Neoplasms

VIN 2“moderate” 1/3-2/3

Epithelium involved

Page 10: Vulva Neoplasms and common benign lesions Maria Horvat, MD, FACOG.

Vulvar Intraepithelial Neoplasms

VIN 3“severe” 2/3 – all

If untreated most go on to cancer

If treated 4% go on to cancer

Treat with wide local excision

Page 11: Vulva Neoplasms and common benign lesions Maria Horvat, MD, FACOG.

Cancer In-Situ

All epithelium involved

Page 12: Vulva Neoplasms and common benign lesions Maria Horvat, MD, FACOG.

New Classification for VIN

Old System New System

VIN 1 Flat condyloma or HPV effect

VIN2,3 VIN, usual type

VIN, warty type

VIN, basaloid type

VIN, mixed (warty/basaloid) type

Differentiated VIN VIN, differentiated type

Page 13: Vulva Neoplasms and common benign lesions Maria Horvat, MD, FACOG.

VIN 3

Page 14: Vulva Neoplasms and common benign lesions Maria Horvat, MD, FACOG.

VIN 3

Page 15: Vulva Neoplasms and common benign lesions Maria Horvat, MD, FACOG.

VIN 3

Page 16: Vulva Neoplasms and common benign lesions Maria Horvat, MD, FACOG.

VIN - Treatment

Local excision

Local destruction

Page 17: Vulva Neoplasms and common benign lesions Maria Horvat, MD, FACOG.

VIN

50% asymptomatic

25% hyperpigmented

Typically: raised surface

Page 18: Vulva Neoplasms and common benign lesions Maria Horvat, MD, FACOG.

VIN – Diagnosis

3% acetic acid

Punch biopsy

Page 19: Vulva Neoplasms and common benign lesions Maria Horvat, MD, FACOG.

Staging of Vulvar Carcinoma

Stage CharacteristicsStage 0 Carcinoma in situ; intraepithelial neoplasia grade III

Stage I Lesion <2 cm; confined to the vulva or perineum; no nodal metastasis

Stage Ia Lesion <2 cm; confined to the vulva or perineum and with stromal invasion <1 mm; no nodal metastasis

Stage Ib Lesion <2 cm; confined to the vulva or perineum and with stromal invasion >1mm; no nodal metastasis

Stage II Tumor >2 cm in greatest dimension; confined to the vulva and/or perineum; no nodal metastasis

Stage III Tumor of any size with adjacent spread to the lower urethra and/or vagina or anus and/or unilateral regional lymph node metastasis

Stage Iva Tumor invasion of any of the following: upper urethra, bladder mucosa, rectal mucosa, and/or pelvic bone and/or bilateral regional node metastases

Stage Ivb Any distant metastasis, including pelvic lymph nodes

Page 20: Vulva Neoplasms and common benign lesions Maria Horvat, MD, FACOG.
Page 21: Vulva Neoplasms and common benign lesions Maria Horvat, MD, FACOG.

Vulvar Cancer – prognostic factors

For nodal involvementSizeDepth of invasionLesion thicknessGradeVascular space involvement

For survivalPositive inguinal nodesPositive pelvic nodes

Page 22: Vulva Neoplasms and common benign lesions Maria Horvat, MD, FACOG.

VIN - Treatment

Cancer-in-situExcision with at least 1cm margins

topical

Invasive CancerInguinal-femoral lymph nodes

Radical excision

Radiation

Pelvic exenteration

Page 23: Vulva Neoplasms and common benign lesions Maria Horvat, MD, FACOG.

Melanoma

Usually arises from nevi

Blue/black

Ulcerated

RX: wide excision with 2 cm free border

If depth of invasion <1.5mm, 100%survival

Page 24: Vulva Neoplasms and common benign lesions Maria Horvat, MD, FACOG.

Vulvar Melanoma

Page 25: Vulva Neoplasms and common benign lesions Maria Horvat, MD, FACOG.

Vulvar Melanoma

Page 26: Vulva Neoplasms and common benign lesions Maria Horvat, MD, FACOG.

Pagets Disease of the Vulva

Hyperemic tissue

Cake icing effect

Rx: wide local excision

30% will develop adenocarcinoma of the breast, colon, and rectum

Page 28: Vulva Neoplasms and common benign lesions Maria Horvat, MD, FACOG.

Lichen Sclerosis

Itching

Diagnosed by biopsy

Can eventually become VIN or vulvar cancer

20% hypothyroid

Page 29: Vulva Neoplasms and common benign lesions Maria Horvat, MD, FACOG.

Lichen Sclerosis

Page 30: Vulva Neoplasms and common benign lesions Maria Horvat, MD, FACOG.

Remember!

BIOPSY anything suspicious!

Page 31: Vulva Neoplasms and common benign lesions Maria Horvat, MD, FACOG.

References

The Female Patient; April 2008

Clinical Gynecology; Bieber

www.Images.MD